Literature DB >> 14113113

THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

S E SVEHAG, B MANDEL.   

Abstract

Rapid formation of poliovirus-neutralizing antibody was observed in the rabbit. 19S type antibody was detectable 8 to 12 hours following a single intravenous virus injection and the induction period was of the order of 4 to 5 hours or less. The production of 7S antibody had a longer lag phase (1(1/2) to 2 days) and it was formed at slower rate. The observed rate of early 19S and 7S antibody formation as well as the peak titers of the two antibodies were antigen dose dependent. Normal rabbit sera showed low neutralizing activity to several viral antigens in a sensitive assay system. Following intravenous inoculation of poliovirus either transitory ( 1 month) or enduring ((3/4) to 1(1/2) year) antibody formation resulted depending upon the dose of antigen employed. In transitory responses, which could be induced by a single small antigen dose, only 19S antibody was demonstrable and there was an abrupt cessation of antibody synthesis on day 4 or 5. In enduring responses, both 19S and 7S antibody were formed and the minimum antigen dose required for initiation of such a response was equal to the dose needed for induction of 7S antibody formation. Thus, enduring antibody formation was an all-or-none phenomenon depending upon whether or not 7S antibody formation was induced. The antigen dose requirement for induction of 7S antibody was much higher (by 50-fold or more) than that for 19S antibody. This allowed a determination of antigen dose regions, within which predictably transitory (19S) or enduring (19S + 7S) antibody formation was obtained. These pronounced differences in antigen dose requirement for induction and kinetics of formation of 19S and 7S antibody suggest that the same cells do not participate in the formation of the two antibodies.

Entities:  

Keywords:  ANTIBODY FORMATION; ANTIGEN-ANTIBODY REACTIONS; COXSACKIE VIRUS INFECTIONS; EXPERIMENTAL LAB STUDY; NEUTRALIZATION TESTS; PHARMACOLOGY; POLIOMYELITIS; POLIOVIRUS; RABBITS; SULFHYDRYL COMPOUNDS; ULTRAVIOLET RAYS

Mesh:

Substances:

Year:  1964        PMID: 14113113      PMCID: PMC2137811          DOI: 10.1084/jem.119.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  The production and properties of poliovirus neutralizing antibody of rabbit origin.

Authors:  S E SVEHAG; B MANDEL
Journal:  Virology       Date:  1962-11       Impact factor: 3.616

2.  Destruction of some agglutinins but not of others by two sulfhydryl compounds.

Authors:  R GRUBB; B SWAHN
Journal:  Acta Pathol Microbiol Scand       Date:  1958

3.  Autoradiographic observations of plasma cell formation.

Authors:  J C SCHOOLEY
Journal:  J Immunol       Date:  1961-03       Impact factor: 5.422

4.  The separation by starch electrophoresis of two antibodies in sheep red cells differing in hemolytic efficiency.

Authors:  P STELOS; D W TALMAGE
Journal:  J Infect Dis       Date:  1957 Mar-Apr       Impact factor: 5.226

5.  Formation of specific antibodies and gamma-globulin in vitro; a study of the synthetic ability of various tissues from rabbits immunized by different methods.

Authors:  B A ASKONAS; J H HUMPHREY
Journal:  Biochem J       Date:  1958-02       Impact factor: 3.857

6.  Antibodies in the rabbit with different rates of metabolic decay.

Authors:  W H TALIAFERRO; D W TALMAGE
Journal:  J Infect Dis       Date:  1956 Jul-Aug       Impact factor: 5.226

7.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

8.  Antibody formation. III. The primary and secondary antibody response to bacteriophage phi X 174 in guinea pigs.

Authors:  J W UHR; M S FINKELSTEIN; J B BAUMANN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

9.  Gamma globulin and antibody formation in vitro. III. Induction of secondary response at different intervals after the primary; the role of secondary nodules in the preparation for the secondary response.

Authors:  G J THORBECKE; R M ASOFSKY; G M HOCHWALD; G W SISKIND
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

10.  Physical properties of antibody to bovine serum albumin as demonstrated by hemagglutination.

Authors:  A A BENEDICT; R J BROWN; R AYENGAR
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

View more
  71 in total

1.  IN VITRO SECONDARY 19S AND 7S ANTIBODY RESPONSES TO POLIOVIRUS IN MEMBRANE CULTURES OF SEPARATED SPLEEN CELLS.

Authors:  S E SVEHAG
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  A comparison of some serological tests for bluetongue virus infection.

Authors:  F C Thomas; A Girard; P Boulanger; G Ruckerbauer
Journal:  Can J Comp Med       Date:  1976-07

3.  Thymus-derived lymphocytes control the expression of immunogenic properties of peritoneal macrophages.

Authors:  E Tzehoval; S Segal; M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Detection of antibodies of the IgM class in sera of patients recently infected with influenza viruses.

Authors:  Y I Buchner; R B Heath; J V Collins; J R Pattison
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

5.  The dynamics of the formation of virus-neutralizing, complement-fixing and immunofluorescent antibodies to the rabies virus in guinea pigs.

Authors:  O Procházka; V Hronovský; H Dubanská
Journal:  Folia Microbiol (Praha)       Date:  1972       Impact factor: 2.099

6.  Mumps class-specific immunoglobulins in radioimmunoassay and conventional serology.

Authors:  H Daugharty; D T Warfield; W D Hemingway; H L Casey
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

7.  BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people.

Authors:  A J Flower; J E Banatvala; I L Chrystie
Journal:  Br Med J       Date:  1977-07-23

8.  Adenovirus antibody measured by the passive hemagglutination test.

Authors:  S S Lefkowitz; J A Williams; B E Howard; M M Sigel
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

9.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. IV. NORMAL ANTIBODY AND EARLY IMMUNE ANTIBODY OF RABBIT ORIGIN: A COMPARISON OF BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES.

Authors:  S E SVEHAG
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.

Authors:  J W Smith; B Kaijser
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.